TherapeuticsMD, Inc. (29TA.F)

9.75 0.00 (0.00%) At close: 03:46PM CEST

TherapeuticsMD, Inc.

951 Yamato Road
Suite 220
Boca Raton, FL 33431
United States
561 961 1900
https://www.therapeuticsmd.com

Sector(s): 
Industry: 
Full-time employees: 1

Key executives

Name	Title	Pay	Exercised	Year born
Governor Thomas G. Thompson	Executive Chairman	148.55k	N/A	1942
Mr. Marlan D. Walker J.D.	Chief Executive Officer	614.07k	N/A	1975
Mr. Joseph A. Ziegler	Principal Financial & Accounting Officer	78.58k	N/A	1974
Mr. Robert G. Finizio	Co-Founder	6.97k	N/A	1971
Mr. Douglas Steelman	Vice President of Market Access	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Corporate governance

TherapeuticsMD, Inc.’s ISS governance QualityScore as of 1 May 2024 is 5. The pillar scores are Audit: 9; Board: 6; Shareholder rights: 2; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.